Breaking News

Metrics Appoints Pharma Development Director

February 5, 2013

Cobb to manage early-phase OSD development

Joseph E. Cobb Jr., CPIP, has been appointed director of pharmaceutical development at Metrics, Inc. Mr. Cobb will manage all aspects of projects that involve early-phase solid oral dosage development. He also will oversee the company’s potent and cytotoxic drug development services, which include a dedicated and segregated potent facility.
 
Mr. Cobb has more than 20 years of industry experience, and holds the Certified Pharmaceutical Industry Professional credential from ISPE. He joined the company in 2002.
 
“Joe is a smart and capable leader who has been instrumental in guiding the success and growth of Metrics’ formulation development capabilities,” said Phil Hodges, president of Metrics. “With these new responsibilities, Joe will bring to his role the same thoughtfulness and resourcefulness.”
blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Successful Method Transfer of Solid Oral Dosage

    Successful Method Transfer of Solid Oral Dosage

    John Frankonis, Ropack Pharma Solutions||June 2, 2016
    The three steps outlined will help guide the process of completing a successful analytical method transfer